Locating BRCA gene mutations to better treat ovarian cancer
Mutations in the BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly increase the risk of certain cancers such as ovarian, breast, pancreatic and prostate cancer. In 2016, a new class of drugs, PARP inhibitors, was found to be very effective against tumors linked to the …
Locating BRCA gene mutations to better treat ovarian cancer Read More »